» Articles » PMID: 26745609

Risk of Cardiovascular Disease from Cumulative Cigarette Use and the Impact of Smoking Intensity

Overview
Journal Epidemiology
Specialty Public Health
Date 2016 Jan 9
PMID 26745609
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Relative risks (RRs) for cardiovascular disease (CVD) by smoking rate exhibit a concave pattern, with RRs in low rate smokers exceeding a linear extrapolation from higher rate smokers. However, cigarettes/day does not by itself fully characterize smoking-related risks. A reexamination of the concave pattern using a comprehensive representation of smoking may enhance insights.

Methods: Data were from the Atherosclerosis Risk in Communities (ARIC) Study, a prospective cohort enrolled in four areas of the US in 1987-1989. Follow-up was through 2008. Analyses included 14,233 participants, 245,915 person-years, and 3,411 CVD events.

Results: The concave RRs with cigarettes/day were consistent with cigarettes/day modifying a linear RR association of pack-years with CVD (i.e., strength of the pack-years association depended on cigarettes/day, indicating that the manner of pack-years accrual impacted risk). Smoking fewer cigarettes/day for longer duration was more deleterious than smoking more cigarettes/day for shorter duration (P < 0.01). For 50 pack-years (365,000 cigarettes), estimated RRs of CVD were 2.1 for accrual at 20 cigarettes/day and 1.6 for accrual at 50 cigarettes/day. Years since smoking cessation did not alter the diminishing strength of association with increasing cigarettes/day. Analyses that accounted for competing risks did not affect findings.

Conclusion: Pack-years remained the primary determinant of smoking-related CVD risk; however, accrual influenced RRs. For equal pack-years, smoking fewer cigarettes/day for longer duration was more deleterious than smoking more cigarettes/day for shorter duration. This observation provides clues to better understanding the biological mechanisms, and reinforces the importance of cessation rather than smoking less to reduce CVD risk.

Citing Articles

Comparing the Association Between Depressive Symptoms and Cardiovascular Disease Among the Middle-Aged and Elderly Population: A National Survey of 9,049 Subjects Based on the Indonesian Family Life Survey-5.

Alfian S, Permata P, Griselda M, Puspitasari I, Abdulah R Vasc Health Risk Manag. 2025; 21:85-95.

PMID: 40026535 PMC: 11871849. DOI: 10.2147/VHRM.S491961.


Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell Carcinoma.

Lam A, Hueniken K, Pienkowski M, Lee J, Dong M, Diergaarde B JAMA Otolaryngol Head Neck Surg. 2025; .

PMID: 39976935 PMC: 11843462. DOI: 10.1001/jamaoto.2024.5392.


Electronic cigarettes and cardiovascular disease: epidemiological and biological links.

Zong H, Hu Z, Li W, Wang M, Zhou Q, Li X Pflugers Arch. 2024; 476(6):875-888.

PMID: 38376568 PMC: 11139732. DOI: 10.1007/s00424-024-02925-0.


Global burden of stroke attributable to secondhand smoke in 204 countries and territories from 1990 to 2019: analysis of the global burden of disease study.

Yang X, Sun J, Zhang W Front Neurol. 2024; 15:1320033.

PMID: 38343713 PMC: 10853451. DOI: 10.3389/fneur.2024.1320033.


Cardiovascular disease outcomes among established cigar users 40 years and older: Findings from the population assessment of tobacco and health (PATH) study, waves 1-5 (2013-2019).

Sharma E, Tang Z, Lauten K, Silveira M, Delnevo C, Edwards K Prev Med Rep. 2024; 37:102569.

PMID: 38186661 PMC: 10767260. DOI: 10.1016/j.pmedr.2023.102569.


References
1.
Etter J, Perneger T . Measurement of self reported active exposure to cigarette smoke. J Epidemiol Community Health. 2001; 55(9):674-80. PMC: 1731967. DOI: 10.1136/jech.55.9.674. View

2.
Law M, Morris J, Watt H, Wald N . The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. Br J Cancer. 1997; 75(11):1690-3. PMC: 2223525. DOI: 10.1038/bjc.1997.287. View

3.
Law M, Wald N . Environmental tobacco smoke and ischemic heart disease. Prog Cardiovasc Dis. 2003; 46(1):31-8. DOI: 10.1016/s0033-0620(03)00078-1. View

4.
Lubin J, Caporaso N, Hatsukami D, Joseph A, Hecht S . The association of a tobacco-specific biomarker and cigarette consumption and its dependence on host characteristics. Cancer Epidemiol Biomarkers Prev. 2007; 16(9):1852-7. DOI: 10.1158/1055-9965.EPI-07-0018. View

5.
Richie Jr J, Carmella S, Muscat J, SCOTT D, Akerkar S, Hecht S . Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev. 1997; 6(10):783-90. View